Federman & Sherwood is pleased to announce that they successfully argued that the Samsung Top-Loading Washing Machine cases filed throughout the United States should be transferred by the Judicial Panel on Multidistrict Litigation to the federal district court in Oklahoma City (Western District of Oklahoma). The litigation concerns at least 26 lawsuits filed in different federal courts. The common allegations arise from claims that over 30 models of Samsung top-load washing machines have design and manufacturing defects that may cause machine parts to detach, break apart, or explode during the spin cycle. Samsung issued a recall in November 2016 which […]

A recent article by Lily Hay Newman of Wired reported after the Congressional Hearing six important issues that came out of the Hearing.  With each new revelation about the devastating Equifax breach, the company’s defenses and response appear increasingly inadequate. To read the complete article, please click here. 

To: All persons and/or entities who purchased common stock in Avalanche Biotechnologies, Inc. [AAVL] during the period between July 30, 2014 and June 15, and were damaged thereby; a settlement has been announced in the securities litigation known as In re: Avalanche Biotechnologies, Inc. Shareholder Litigation, CIV536488 (Superior Court of the State of Californioa, County of San Mateo) For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is December 27, 2017. If you have any questions […]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against SCANA Corporation Oklahoma City, OK (September 29, 2017) – On September 27, 2017, a securities class action lawsuit was filed in the United States District Court for the District of South Carolina against SCANA Corporation (NYSE: SCG). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which […]

To: All persons who used AshleyMadison.com on or before July 20, 2015, you may be eligible to receive benefits from the class action known as In re: Ashley Madison Customer Data Security Breach Litigation, Case No. 4:15-md-02669-JAP, filed in the United States District Court for the Eastern District of Missouri. The Court entered an Order Granting Preliminary Approval of Settlement, Directing Notice to the Class, Scheduling a Final Approval Hearing, and Certifying a Settlement Class, click here to view the Order. If you wish to receive settlement benefits and are eligible, you will need to submit a claim form directly to the settlement administrator. The […]

To: All persons and/or entities who purchased common stock in THQ, Inc.[THQI] during the period from May 3, 2011 to February 2, 2012 and were damaged thereby; a settlement has been announced in the securities litigation known as Zaghian v. THQ Inc., et al, 2:12-cv-05227-MLR-JEM, in the United States District Court for the Central District of California.  For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is October 2, 2017. If you have any […]

To: All persons and/or entities who purchased common stock in Ocwen Financial Corporation [OCN] during the period from May 2, 2013 to December 19, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as In re:  Ocwen Financial Corporation Securities Litigation, Civil Action No. 14-81057, United States District Court for the Southern District of Florida. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is December 8, […]

To: All current stockholders of Dynavax Technologies Corporation (NASDAQ: DVAX). The Superior Court of the State of California, County of Alameda, has granted preliminary approval for the settlement of certain derivative claims brought nominally for the benefit of Dynavax Technologies Corporation (Case No. RG13686266, styled Truglio v. Oronsky, et al).  A final hearing on the proposed settlement is scheduled for October 17, 2017 at 3:00 p.m., before the Honorable Brad Seligman, Department 30 in the Superior Court of the State of California, Alameda County, located at U.S. Post Office Building, 201 Thirteenth Street, Oakland, California 94613. For additional information, please see […]

To: All persons and/or entities who purchased common stock in Textura Corporation [TXTR] during the period from June 7, 2013 and January 7, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as Fred Kelsey v. Patrick J. Allin, et al., Case No. 14-cv-7837 (N.D.Ill.), United States District Court for the Northern District of Illinois. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is OCTOBER 23, 2017. If you […]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Akari Therapeutics, Plc Oklahoma City, OK (May 15, 2017) – On May 12, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against Akari Therapeutics, Plc (NASDAQ: AKTX). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the […]